Emicizumab use in major orthopedic surgery

Blood Adv. 2019 Jun 11;3(11):1722-1724. doi: 10.1182/bloodadvances.2019000228.

Abstract

  1. Major orthopedic surgery can be performed safely in hemophilia patients with inhibitors receiving emicizumab.

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Bispecific / administration & dosage*
  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Hemophilia A / therapy*
  • Humans
  • Male
  • Middle Aged
  • Orthopedic Procedures*

Substances

  • Antibodies, Bispecific
  • Antibodies, Monoclonal, Humanized
  • emicizumab